Brief: Clearmind Medicine Completes The Initiation Of Its Alcohol Use Disorder Phase I/IIA Clinical Trial At All Current Clinical Sites
23/04/2025 13:37
April 23 (Reuters) - Clearmind Medicine Inc CMND.O: CLEARMIND MEDICINE COMPLETES THE INITIATION OF ITS ALCOHOL USE DISORDER PHASE I/IIA CLINICAL TRIAL AT ALL CURRENT CLINICAL SITES Source text: ID:nGNX7NW8PW Further company coverage: CMND.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clearmind Medicine
See all newsBrief: Clearmind Advances Dialogue With U.S. Federal Government On Psychedelic Therapies, Submitting Recommendations To FDA
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM